High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS

Table 4

Cox regression analysis at 12-month followup.

	Univariate		Multivariate*
Condition	HR (95% CI)	𝑃	HR (95% CI)	𝑃
hsTnT > 0.013 ng/mL	3.29 (1.33–8.11)	0.010	2.74 (1.08–6.95)	0.034
Copeptin > 14 pmol/L	0.04 (0.00–14.78)	0.285
age > 65 years	3.15 (1.20–8.31)	0.020	2.52 (0.88–7.21)	0.111
Severe symptoms	1.65 (0.65–4.17)	0.294
≥3 CVRF	2.00 (0.75–5.32)	0.167
Previous non-STEACS	4.35 (1.68–11.26)	0.002	4.02 (1.55–10.43)	0.004
ST deviation	1.14 (0.32–3.95)	0.841

^*Multivariate analysis by conditional method. ≥3 CVRF: at least three cardiovascular risk factors. Previous non-STEACS: previous non-ST elevation acute coronary syndrome. HR: hazard ratio. CI: confidence interval.